Maria Ekblad
Technik-/Wissenschafts-/F&E-Leiter bei FOLLICUM AB (PUBL)
Aktive Positionen von Maria Ekblad
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FOLLICUM AB (PUBL) | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Geschäftsführer | 14.01.2022 | - |
Karriereverlauf von Maria Ekblad
Ausbildung von Maria Ekblad
| University of Lund | Graduate Degree |
Statistik
International
| Schweden | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Follicum AB is a biotech company, which engages in discovery and development of peptide-based drugs. Its product pipeline include FOL-005, FOL-00X, FOL-014, and FOL-00Y which is made for stimulation of hair growth and treatment of diabetes. The company was founded by Anna Kerstin Emy Hultgårdh Nilsson and Claes Pontus Dunér on May 3, 2011 and is headquartered in Lund, Sweden. | Health Technology |
- Börse
- Insiders
- Maria Ekblad
- Erfahrung
